Eska Pharma SPRL
Eska Pharma reported total assets of €1.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Eska Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eska Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 28 Oct 2025
- Year ended 31 Dec 2023filed on 29 Oct 2024
- Year ended 31 Dec 2022filed on 31 Oct 2023
- Year ended 31 Dec 2021filed on 16 Jan 2023
Eska Pharma's financial analysis
- Solvency40.9%sector median: 50.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eska Pharma
Eska Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0840.007.528
- VAT number
- BE0840007528
- Peppol
- Registered · 0208:0840007528 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 06 Oct 2011
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Eska Pharma (SPRL) has been based in Brussels since 2011, active in: business and other management consultancy activities. For 2025, it reports a net profit of 105,760 € and equity of 690,490 €; its revenue is not published. Its solvency stands at 40.9%, below the median of its sector (50.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eska Pharma
Companies in the same business, of comparable size and area, outside its group.
- Ayrton Beys Holding Business and other management consultancy activities Kampenhout · balance sheet €1.69m
- Yella Business and other management consultancy activities Beringen · balance sheet €1.69m
- Lobelia Business and other management consultancy activities Lo-Reninge · balance sheet €1.69m
- Verler Business and other management consultancy activities Ypres · balance sheet €1.68m
- Asymptote Business and other management consultancy activities Silly · balance sheet €1.69m
- ChriMarc Business and other management consultancy activities Crisnée · balance sheet €1.69m
- Dinara Business and other management consultancy activities Leuven · balance sheet €1.69m
- Trypack Agro Business and other management consultancy activities Houthulst · balance sheet €1.68m
Frequently asked questions about Eska Pharma
What is the revenue of Eska Pharma?
Eska Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eska Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0840007528 for Eska Pharma, if the company is VAT-registered. Its company number (CBE) is 0840.007.528.
Where is the registered office of Eska Pharma?
According to the CBE register, the registered office of Eska Pharma is in 1000 Brussels.
What is the equity of Eska Pharma?
At the close of the 2025 financial year, the equity of Eska Pharma amounts to 690,490 €, a solvency of 40.9% of total assets.
Who manages Eska Pharma?
The register lists 1 active mandates at Eska Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eska Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →